MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancer

By sjmartinez • October 11, 2023

Crowell PD, Giafaglione JM, Jones AE, Nunley NM, Hashimoto T, Delcourt AML, Petcherski A, Agrawal R, Bernard MJ, Diaz JA, Heering KY, Huang RR, Low JY, Matulionis N, Navone NM, Ye H, Zoubeidi A, Christofk HR, Rettig MB, Reiter RE, Haffner MC, Boutros PC, Shirihai OS, Divakaruni AS, Goldstein AS. MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancer. Cell Rep. 2023 Oct 9;42(10):113221. doi: 10.1016/j.celrep.2023.113221. Epub ahead of print. PMID: 37815914.

Tags: Cancer, CP, Endocrinology, Metabolism, Publications

Bone Mineral Density Measurements and Fracture Prediction in the Very Elderly

Borenstein J, Maletkovic J, DuVall J, Sharifi M. Bone Mineral Density Measurements and Fracture Prediction in the Very Elderly. Cureus. 2025 Nov 21;17(11):e97458. doi: 10.7759/cureus.97458.[...]

UTX coordinates TCF1 and STAT3 to control progenitor CD8+ T cell fate in autoimmune diabetes

Chen HC, Bang MF, Wang HH, Shpargel KB, Kohn LA, Sailer D, Zhang S, McCarthy EC, Seyedsadr M, Stevens S, Pham CLH, Zhou Z, Yin[...]

Metabolic Acidosis in Chronic Alcoholism: When It’s Not Just Diabetic Ketoacidosis

Li R, Han J, Sidhu H. Metabolic Acidosis in Chronic Alcoholism: When It's Not Just Diabetic Ketoacidosis. Cureus. 2025 Nov 11;17(11):e96632. doi: 10.7759/cureus.96632. PMID: 41393585;[...]